In the United States, Joe Rogan, a prominent podcaster, has voiced his concerns regarding the use of antidepressants by fellow comedian and podcaster Theo Von. This discussion occurred in a recent episode of 'The Joe Rogan Experience,' where Rogan encouraged Von to consider stopping his medication, suggesting that it might be affecting his mental well-being negatively. This conversation unfolded after Von had appeared on Rogan's podcast in April, during which they discussed his struggles with depression and the impact of prescription medications like Selective Serotonin Reuptake Inhibitors (SSRIs). Theo Von has been candid about his battle with depression and has publicly shared that he has relied on antidepressants for a long time. The concern escalated when Rogan referenced a troubling moment from Von's past, particularly when he performed a Netflix comedy special while struggling with his mental health. In that instance, Von expressed to his audience that he was trying not to take his own life, a statement that deeply unsettled Rogan, prompting him to emphasize the importance of helping Von navigate this difficult period. Rogan's worry stems from his belief that there could be a link between SSRIs and suicidal thoughts, a possibility he elaborated upon based on his observations of others who have experienced negative outcomes while on antidepressants. He acknowledged that while some individuals have found SSRIs beneficial, there have also been alarming instances where those on these medications have taken their lives. This heightened awareness about the potential risks associated with SSRIs has placed Rogan in a position where he feels compelled to advocate for Von's discontinuation of the medication. The widespread usage of SSRIs as a primary antidepressant is well-documented, with extensive studies indicating their effectiveness over placebo treatments. However, these findings have been met with scrutiny, particularly regarding their long-term effects and the risks associated with their use. An FDA safety review highlighted the increased risk of suicidal thoughts in young individuals, leading experts to caution that mental health professionals must balance the benefits of medication against these potential dangers. The public discourse surrounding antidepressants has intensified, with figures like health advocate Robert F. Kennedy Jr. addressing the issue and advocating for reduced prescriptions. This larger conversation reflects the ongoing struggle to find a safe and effective approach to treating mental health conditions like depression, and highlights the need for continued examination of the psychological and physiological impacts of these medications.